Wegovy and Zepbound are 2 FDA-approved injectables for weight loss. Learn how they compare in benefits, side effects, and ...

Both semaglutide and tirzepatide are associated with improvements in quality of life for adults with obesity, though ...

Trump launches "TrumpRx" program to cut prices of Wegovy and Zepbound, making weight-loss drugs more affordable for Americans ...

The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with ...

Trump secures a major deal with Eli Lilly and Novo Nordisk to cut obesity drug costs as Medicare expands coverage for Zepbound and Wegovy by 2026.

Eli Lilly’s Zepbound push is getting a “Queer Eye” makeover with the help of fashion expert Tan France, who is joining the ...

The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...

Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing ...

Novo Nordisk A/S is undercutting archrival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to ...

Intracranial electroencephalography measured the brain activity of a patient with obesity and loss-of-control eating after ...